Open AccessAnti-PD-L1 Antibody Continues to Show Good Activity Against Melanoma, with Low Toxicity
Author(s) -
Daniel M. Keller
Publication year - 2014
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000443160.10232.3a
Subject(s) - medicine , melanoma , ipilimumab , antibody , immunotherapy , cancer , tumor microenvironment , immune checkpoint , oncology , immune system , cancer research , immunology